BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 8174090)

  • 1. Clonal chromosome aberrations in three sacral chordomas.
    Mertens F; Kreicbergs A; Rydholm A; Willén H; Carlén B; Mitelman F; Mandahl N
    Cancer Genet Cytogenet; 1994 Apr; 73(2):147-51. PubMed ID: 8174090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromosomal abnormalities in two chordomas.
    Gibas Z; Miettinen M; Sandberg AA
    Cancer Genet Cytogenet; 1992 Feb; 58(2):169-73. PubMed ID: 1551083
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of isochromosome 1q as a recurring chromosome aberration in skull base chordomas: a new marker for aggressive tumors?
    Sawyer JR; Husain M; Al-Mefty O
    Neurosurg Focus; 2001 Mar; 10(3):E6. PubMed ID: 16734409
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytogenetic analysis of two sacral chordomas.
    Persons DL; Bridge JA; Neff JR
    Cancer Genet Cytogenet; 1991 Oct; 56(2):197-201. PubMed ID: 1756464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cytogenetic analysis of a parachordoma.
    Tihy F; Scott P; Russo P; Champagne M; Tabet JC; Lemieux N
    Cancer Genet Cytogenet; 1998 Aug; 105(1):14-9. PubMed ID: 9689924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytogenetic and molecular cytogenetic analysis of sacral chordoma.
    Bridge JA; Pickering D; Neff JR
    Cancer Genet Cytogenet; 1994 Jul; 75(1):23-5. PubMed ID: 8039159
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genome-wide analysis of sixteen chordomas by comparative genomic hybridization and cytogenetics of the first human chordoma cell line, U-CH1.
    Scheil S; Brüderlein S; Liehr T; Starke H; Herms J; Schulte M; Möller P
    Genes Chromosomes Cancer; 2001 Nov; 32(3):203-11. PubMed ID: 11579460
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-random chromosome rearrangements in adenoid cystic carcinoma of the salivary glands.
    Nordkvist A; Mark J; Gustafsson H; Bang G; Stenman G
    Genes Chromosomes Cancer; 1994 Jun; 10(2):115-21. PubMed ID: 7520264
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chromosome aberrations and cytogenetic intratumor heterogeneity in chondrosarcomas.
    Orndal C; Mandahl N; Rydholm A; Willén H; Brosjö O; Mitelman F
    J Cancer Res Clin Oncol; 1993; 120(1-2):51-6. PubMed ID: 8270609
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromosome abnormalities in colorectal adenomas: two cytogenetic subgroups characterized by deletion of 1p and numerical aberrations.
    Bomme L; Bardi G; Pandis N; Fenger C; Kronborg O; Heim S
    Hum Pathol; 1996 Nov; 27(11):1192-7. PubMed ID: 8912830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HOXA7, HOXA9, and HOXA10 are differentially expressed in clival and sacral chordomas.
    Jäger D; Barth TFE; Brüderlein S; Scheuerle A; Rinner B; von Witzleben A; Lechel A; Meyer P; Mayer-Steinacker R; Baer AV; Schultheiss M; Wirtz CR; Möller P; Mellert K
    Sci Rep; 2017 May; 7(1):2032. PubMed ID: 28515451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chromosome aberrations in four ependymomas.
    Sawyer JR; Sammartino G; Husain M; Boop FA; Chadduck WM
    Cancer Genet Cytogenet; 1994 Jun; 74(2):132-8. PubMed ID: 8019957
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytogenetic studies of primary cultures of esophageal squamous cell carcinoma.
    Rosenblum-Vos LS; Meltzer SJ; Leana-Cox J; Schwartz S
    Cancer Genet Cytogenet; 1993 Oct; 70(2):127-31. PubMed ID: 8242593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytogenetic analysis of three variants of clival chordoma.
    Gil Z; Fliss DM; Voskoboinik N; Leider-Trejo L; Spektor S; Yaron Y; Orr-Urtreger A
    Cancer Genet Cytogenet; 2004 Oct; 154(2):124-30. PubMed ID: 15474147
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Frequent deletion of the CDKN2A locus in chordoma: analysis of chromosomal imbalances using array comparative genomic hybridisation.
    Hallor KH; Staaf J; Jönsson G; Heidenblad M; Vult von Steyern F; Bauer HC; Ijszenga M; Hogendoorn PC; Mandahl N; Szuhai K; Mertens F
    Br J Cancer; 2008 Jan; 98(2):434-42. PubMed ID: 18071362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytogenetic survey of 32 cancers of the prostate.
    Arps S; Rodewald A; Schmalenberger B; Carl P; Bressel M; Kastendieck H
    Cancer Genet Cytogenet; 1993 Apr; 66(2):93-9. PubMed ID: 8500107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Establishment and detailed functional and molecular genetic characterisation of a novel sacral chordoma cell line, MUG-Chor1.
    Rinner B; Froehlich EV; Buerger K; Knausz H; Lohberger B; Scheipl S; Fischer C; Leithner A; Guelly C; Trajanoski S; Szuhai K; Liegl B
    Int J Oncol; 2012 Feb; 40(2):443-51. PubMed ID: 22002331
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chromosome 3p loss of heterozygosity and reduced expression of H3K36me3 correlate with longer relapse-free survival in sacral conventional chordoma.
    Zhu GG; Ramirez D; Chen W; Lu C; Wang L; Frosina D; Jungbluth A; Ntiamoah P; Nafa K; Boland PJ; Hameed MR
    Hum Pathol; 2020 Oct; 104():73-83. PubMed ID: 32795465
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytogenetic investigation of chordomas of the skull.
    Buonamici L; Roncaroli F; Fioravanti A; Losi L; Van den Berghe H; Calbucci F; Dal Cin P
    Cancer Genet Cytogenet; 1999 Jul; 112(1):49-52. PubMed ID: 10432936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of cytogenetic abnormalities on the management of skull base chordomas.
    Almefty KK; Pravdenkova S; Sawyer J; Al-Mefty O
    J Neurosurg; 2009 Apr; 110(4):715-24. PubMed ID: 19133754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.